Alkermes (ALKS) PT Raised to $32 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cantor Fitzgerald Reiterates Overweight Rating on Alkermes (ALKS)
February 13, 2025 9:28 AM ESTCantor Fitzgerald analyst Dr Charles Duncan reiterated an Overweight rating and $43.00 price target on Alkermes (NASDAQ: ALKS).
He said, "Trading at EV/FY25 sales = 3.7x, we believe ALKS shares remain compelling as a differentiated core holding for patient investors in front of... More
Alkermes (ALKS) PT Raised to $38 at TD Cowen
February 13, 2025 8:36 AM ESTTD Cowen analyst Joseph Thome raised the price target on Alkermes (NASDAQ: ALKS) to $38.00 (from $35.00) while maintaining a Buy rating.... More
Jefferies Reiterates Buy Rating on Alkermes (ALKS)
February 12, 2025 1:18 PM ESTJefferies analyst Akash Tewari reiterated a Buy rating and $41.00 price target on Alkermes (NASDAQ: ALKS).
The analyst comments "ALKS reported a beat in Q4 on both total revs ($430M vs $356M cons) & non-GAAP EPS ($1.04 vs $0.72 cons) - Lybalvi revs were $77M... More
Alkermes (ALKS) Tops Q4 EPS by 30c
February 12, 2025 7:01 AM ESTAlkermes (NASDAQ: ALKS) reported Q4 EPS of $1.05, $0.30 better than the analyst estimate of $0.75. Revenue for the quarter came in at $430 million versus the consensus estimate of $380.75 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
... MoreDeutsche Bank Starts Alkermes (ALKS) at Buy
February 11, 2025 4:11 AM ESTDeutsche Bank analyst David Hoang initiates coverage on Alkermes (NASDAQ: ALKS) with a Buy rating and a price target of $40.00.
The analyst comments: "ALKS shares have been largely rangebound over the past year, but we believe the company has a potential best-in-class orexin receptor... More
